Reduction in newborns with discharge coding of in utero alcohol effects in the United States, 1993 to 2002

Archives of Pediatrics and Adolescent Medicine

Volumn 160, Issue 12, 2006, Pages 1224-1231

  Robbins, James M ^a,b   Bird, T M ^b   Tilford, John M ^a,b   Reading, J Alex ^b   Cleves, Mario A ^a,b   Aitken, Mary E ^b   Druschel, Charlotte M ^c   Hobbs, Charlotte A ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b ARKANSAS CHILDREN S HOSPITAL   (United States)

^c NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; FETAL ALCOHOL SYNDROME; GENERAL HOSPITAL; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INFANT; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MATERNAL CARE; MEDICAL DOCUMENTATION; NEWBORN; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; SELF REPORT; UNITED STATES;

ALCOHOL DRINKING; DATABASES, FACTUAL; ETHANOL; FEMALE; FETAL ALCOHOL SYNDROME; HUMANS; INFANT, NEWBORN; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICAL RECORDS; PATIENT DISCHARGE; PREGNANCY; UNITED STATES;

EID: 33845414119     PISSN: 10724710     EISSN: 10724710     Source Type: Journal    
DOI: 10.1001/archpedi.160.12.1224     Document Type: Article

References (48)

1. Beck LF, Johnson CH, Morrow B, et al. PRAMS 1999 Surveillance Report. Atlanta, Ga: Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention; 2003.
2. Astley SJ. Fetal alcohol syndrome prevention in Washington State: evidence of success. Paediatr Perinat Epidemiol. 2004;18:344-351.
3. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1988.
4. Use of. International Classification of Diseases coding to identify fetal alcohol syndrome-Indian Health Service facilities, 1981-1992. MMWR Morb Mortal Wkly Rep. 1995;44:253-255, 261.
5. Hoyme HE. A practical clinical approach to diagnosis of fetal alcohol spectrum disorders: clarification of the 1996 Institute of Medicine criteria: in reply. Pediatrics. 2005;115:1787.
6. O'Leary CM. Fetal alcohol syndrome: diagnosis, epidemiology, and developmental outcomes. J Paediatr Child Health. 2004;40:2-7.
7. Institute of Medicine. Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment. Washington, DC: National Academy Press; 1996.
8. Bertrand J, Floyd RL, Weber MK, et al. Fetal Alcohol Syndrome: Guidelines for Referral and Diagnosis, 1-50. Atlanta, Ga: Centers for Disease Control and Prevention; 2004.
9. Fox DJ, Druschel CM. Estimating prevalence of fetal alcohol syndrome (FAS): effectiveness of a passive birth defects registry system. Birth Defects Res Part A Clin Mol Teratol. 2003;67:604-608.
10. Miller LA, Shaikh T, Stanton C, et al. Surveillance for fetal alcohol syndrome in Colorado. Public Health Rep. 1995;110:690-696.
11. Bertrand J, Floyd LL, Weber MK. Guidelines for identifying and referring persons with fetal alcohol syndrome. MMWR Recomm Rep. 2005;54:1-14.
12. Coles CD, Kable JA, Drews-Botsch C, Falek A. Early identification of risk for effects of prenatal alcohol exposure. J Stud Alcohol. 2000;61:607-616.
13. Streissguth AP, Barr HM, Kogan J, Bookstein FL. Understanding the Occurrence of Secondary Disabilities in Clients With Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Effects (FAE): Final Report. Seattle: University of Washington Publications Services; 1996.
14. The HCUP Nationwide Inpatient Sample (NIS). Rockville, Md: Agency for Healthcare Research and Quality; 2004.
15. KIDS' Inpatient Database (KID):The HCUP. Rockville, Md: Agency for Healthcare Research and Quality; 2003.
16. Bird TM, Hobbs CA, Cleves MA, Tilford JM, Robbins JM. National rates of birth defects among hospitalized newborns. Birth Defects Res Part A Clin Mol Teratol. In press.
17. Robbins JM, Tilford JM, Bird TM, Cleves MA, Reading JA, Hobbs CA. Hospitalizations of newborns with folate-sensitive birth defects before and after fortification of foods with folic acid. Pediatrics. In press.
18. Holman RC, Curns AT, Belay ED, Steiner CA, Schonberger LB. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics. 2003;112:495-501.
19. Odetola FO, Tilford JM, Davis MM. Variation in the use of intracranial pressure monitoring and mortality in critically ill children with meningitis in the United States. Pediatrics. 2006;117:1893-1900.
20. Fetal alcohol syndrome - United States, 1979-1992. MMWR Morb Mortal Wkly Rep. 1993;42:339-341.
21. Update: trends in fetal alcohol syndrome - United States, 1979-1993. MMWR Morb Mortal Wkly Rep. 1995;44:249-251.
22. Abel EL, Sokol RJ. A revised conservative estimate of the incidence of FAS and its economic impact. Alcohol Clin Exp Res. 1991;15:514-524.
23. Leung KM, Elashoff RM, Rees KS, Hasan MM, Legorreta AP. Hospital- and patient-related characteristics determining maternity length of stay: a hierarchical linear model approach. Am J Public Health. 1998;88:377-381.
24. Garcia FA, Miller HB, Huggins GR, Gordon TA. Effect of academic affiliation and obstetric volume on clinical outcome and cost of childbirth. Obstet Gynecol. 2001;97:567-576.
25. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Ga: US Dept of Health and Human Services, Centers for Disease Control and Prevention; 2004:1993-2002.
26. Ernhart CB, Morrow-Tlucak M, Sokol RJ, Martier S. Underreporting of alcohol use in pregnancy. Alcohol Clin Exp Res. 1988;12:506-511.
27. Westfall JM, McGloin J. Impact of double counting and transfer bias on estimated rates and outcomes of acute myocardial infarction. Med Care. 2001;39:459-468.
28. Edmonds LD, Layde PM, James LM, Flynt JW, Erickson JD, Oakley GP Jr. Congenital malformations surveillance: two American systems. Int J Epidemiol. 1981;10:247-252.
29. Windham GC, Edmonds LD. Current trends in the incidence of neural tube defects. Pediatrics. 1982;70:333-337.
30. Lynberg MC, Chavez GF, Edmonds LD, Mulinare J. Evaluation of the birth defects monitoring program, 1982-1985. Teratology. 1993;48:650-657.
31. Hoffman JD, Shanske A. Trends in fetal alcohol syndrome. Int Pediatr. 2003;18:114-118.
32. Greenfield TK, Kaskutas LA. Five years exposure to the alcohol warning label messages and their impacts: evidence from diffusion analysis. Appl Behav Sci Rev. 1998;6:39-68.
33. Hankin JR, Sloan JJ, Firestone IJ, Ager JW, Sokol RJ, Martier SS. Has awareness of the alcohol warning label reached its upper limit? Alcohol Clin Exp Res. 1996;20:440-444.
34. Kaskutas LA, Graves K. Relationship between cumulative exposure to health messages and awareness and behavior-related drinking during pregnancy. Am J Health Promot. 1994;9:115-124.
35. Kaskutas LA. Understanding drinking during pregnancy among urban American Indians and African Americans: health messages, risk beliefs, and how we measure consumption. Alcohol Clin Exp Res. 2000;24:1241-1250.
36. Sokol RJ, Martier SS, Ager JW. The T-ACE questions: practical prenatal detection of risk-drinking. Am J Obstet Gynecol. 1989;160:863-868.
37. Hankin JR, Sloan JJ, Sokol RJ. The modest impact of the alcohol beverage warning label on drinking during pregnancy among a sample of African American women. J Public Policy Marketing. 1998;17:61-69.
38. National Birth Defects Prevention Network. State birth defects surveillance program directory. Birth Defects Res Part A Clin Mol Teratol. 2005;73:700-757.
39. Sampson PD, Streissguth AP, Bookstein FL, et al. Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology. 1997;56:317-326.
40. Burd L, Martsolf JT, Klug MG, Kerbeshian J. Diagnosis of FAS: a comparison of the fetal alcohol syndrome diagnostic checklist and the Institute of Medicine Criteria for fetal alcohol syndrome. Neurotoxicol Teratol. 2003;25:719-724.
41. Hymbaugh K, Miller LA, Druschel CM, Podvin DW, Meaney FJ, Boyle CA. A multiple source methodology for the surveillance of fetal alcohol syndrome - The Fetal Alcohol Syndrome Surveillance Network (FASSNet). Teratology. 2002;66(suppl 1):S41-S49.
42. Meaney FJ, Miller LA. A comparison of fetal alcohol syndrome surveillance network and birth defects surveillance methodology in determining prevalence rates of fetal alcohol syndrome. Birth Defects Res Part A Clin Mol Teratol. 2003;67:819-822.
43. Jones KL. From recognition to responsibility: Josef Warkany, David Smith, and the fetal alcohol syndrome in the 21st century. Birth Defects Res Part A Clin Mol Teratol. 2003;67:13-20.
44. Lyons Jones K. Early recognition of prenatal alcohol effects: a pediatrician responsibility. J Pediatr. 1999;135:405.
45. Aase JM. Clinical recognition of FAS: difficulties of detection and diagnosis. Alcohol Res Health. 1994;18:5-9.
46. Little BB, Snell LM, Rosenfeld CR, Gilstrap LC III, Gant NF. Failure to recognize fetal alcohol syndrome in newborn infants. AJDC. 1990;144:1142-1146.
47. Streissguth AP, Aase JM, Clarren SK, Randels SP, LaDue RA, Smith DF. Fetal alcohol syndrome in adolescents and adults. JAMA. 1991;265:1961-1967.
48. May PA, Gossage JP. Estimating the prevalence of fetal alcohol syndrome: a summary. Alcohol Res Health. 2001;25:159-167.